Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Kessler

Orthopaedic Surgery Little Rock, AR Doctor of Osteopathy

NPI 1174684229 CMS profile 880467

9500 Baptist Health Dr Ste 210, Little Rock, AR 72205

Open in the dashboard

General payments

$23,815

232 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adam Kessler of Little Rock, AR is reported in the CMS Open Payments database as having received $23,815 across 232 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,312 50
2024 General $4,405 46
2023 General $543 8
2022 General $2,926 17
2021 General $6,520 44
2020 General $3,697 40
2019 General $2,411 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Kessler
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Adam Kessler were reported at $3,312. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Adam Kessler Orthopaedic Surgery median Middle half National median
2019 $2,411 $644 $140–$2,844 $163
2020 $3,697 $312 $75–$1,860 $114
2021 $6,520 $520 $117–$2,495 $132
2022 $2,926 $598 $128–$2,731 $149
2023 $543 $461 $128–$2,264 $160
2024 $4,405 $497 $134–$2,475 $164
2025 $3,312 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $7,034 102 payments
  2. Smith+Nephew, Inc. $3,884 17 payments
  3. Titan Surgical Group, LLC $3,192 4 payments
  4. TriMed, Inc. $2,776 23 payments
  5. Arthrex, Inc. $2,259 19 payments
  6. Acumed LLC $1,735 15 payments
  7. Paragon 28, Inc. $931 7 payments
  8. DePuy Synthes Sales Inc. $774 13 payments
  9. US Implant Solutions, LLC $193 1 payment
  10. Djo, LLC $187 8 payments
  11. Other $851 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $10,402 31 payments
  2. Food and Beverage $9,347 195 payments
  3. Education $3,816 5 payments
  4. Grant $250 1 payment
Products named General payments · program years 2019–2025
  1. EVOS $3,008 11 payments
  2. PRO $2,463 14 payments
  3. Tools - AFS $2,136 13 payments
  4. Clavicle Plating System $1,327 7 payments
  5. TRIGEN $1,300 6 payments
  6. Polarus 3 Solution $1,275 4 payments
  7. PELVIS II $1,080 9 payments
  8. T2 ALPHA $1,064 21 payments
  9. TRIGEN INTERTAN $867 4 payments
  10. GAMMA $860 21 payments
  11. Other $13,053 159 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

56

Median for Orthopedic Surgery: 203

Drug cost

$340

Median for Orthopedic Surgery: $1,433

Branded share of claims

78.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 44 $312
Tramadol Hcl Generic 12 $29

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$88,241

Medicare's payments for the services billed

Medicare patients

156

Average age 79

Services billed

635

118 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 62%
Depression 47%
Ischemic heart disease 42%
Atrial fibrillation 39%
Chronic kidney disease 38%
Osteoporosis 38%
Diabetes 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

232 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Arkansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record